Microbubbles coupled to methotrexate-loaded liposomes for ultrasound-mediated delivery of methotrexate across the blood–brain barrier

Xiang Wang,1 Ping Liu,1 Weixiao Yang,1 Lu Li,1 Peijing Li,2 Zheng Liu,1 Zhongxiong Zhuo,1 Yunhua Gao1 1Department of Ultrasound, Xinqiao Hospital of the Third Military Medical University, Chongqing, 2Department of Ultrasound, General Hospital of the Jinan Military Area, Jinan, Pe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wang X, Liu P, Yang W, Li L, Li P, Liu Z, Zhuo Z, Gao Y
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://doaj.org/article/1df4c18cd94d456face78fd477394614
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1df4c18cd94d456face78fd477394614
record_format dspace
spelling oai:doaj.org-article:1df4c18cd94d456face78fd4773946142021-12-02T00:06:57ZMicrobubbles coupled to methotrexate-loaded liposomes for ultrasound-mediated delivery of methotrexate across the blood–brain barrier1178-2013https://doaj.org/article/1df4c18cd94d456face78fd4773946142014-10-01T00:00:00Zhttp://www.dovepress.com/microbubbles-coupled-to-methotrexate-loaded-liposomes-for-ultrasound-m-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013 Xiang Wang,1 Ping Liu,1 Weixiao Yang,1 Lu Li,1 Peijing Li,2 Zheng Liu,1 Zhongxiong Zhuo,1 Yunhua Gao1 1Department of Ultrasound, Xinqiao Hospital of the Third Military Medical University, Chongqing, 2Department of Ultrasound, General Hospital of the Jinan Military Area, Jinan, People’s Republic of China Abstract: Methotrexate (MTX) is the single most effective agent for the treatment of primary central nervous system lymphoma. Currently, the delivery of MTX to the brain is achieved by high systemic doses, which cause severe long-term neurotoxicity, or intrathecal administration, which is highly invasive and may lead to infections or hemorrhagic complications. Acoustically active microbubbles have been developed as drug carriers for the noninvasive and brain-targeted delivery of therapeutics. However, their application is limited by their low drug-loading capacity. To overcome this limitation, we prepared microbubbles coupled to MTX-loaded liposomes using ZHIFUXIAN, a novel type of microbubbles with a superior safety profile and long circulation time. MTX-liposome-coupled microbubbles had a high drug-loading capacity of 8.91%±0.86%, and their size (2.64±0.93 µm in diameter) was suitable for intravenous injection. When used with ultrasound, they showed more potent in vitro cytotoxicity against Walker-256 cancer cells than MTX alone or MTX-loaded liposomes. When Sprague-Dawley rats were exposed to sonication, administration of these MTX-liposome-coupled microbubbles via the tail vein led to targeted disruption of the blood–brain barrier without noticeable tissue or capillary damage. High-performance liquid chromatography analysis of the brain MTX concentration showed that MTX delivery to the brain followed the order of MTX-liposome-coupled microbubbles + ultrasound (25.3±2.4 µg/g) > unmodified ZHIFUXIAN + MTX + ultrasound (18.6±2.2 µg/g) > MTX alone (6.97±0.75 µg/g) > MTX-liposome-coupled microbubbles (2.92±0.39 µg/g). Therefore, treatment with MTX-liposome-coupled microbubbles and ultrasound resulted in a significantly higher brain MTX concentration than all other treatments (P<0.01). These results suggest that MTX-liposome-coupled microbubbles may hold great promise as new and effective therapies for primary central nervous system lymphoma and other central nervous system malignancies. Keywords: methotrexate, microbubbles, ultrasound, liposomes, blood–brain barrierWang XLiu PYang WLi LLi PLiu ZZhuo ZGao YDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2014, Iss Issue 1, Pp 4899-4909 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Wang X
Liu P
Yang W
Li L
Li P
Liu Z
Zhuo Z
Gao Y
Microbubbles coupled to methotrexate-loaded liposomes for ultrasound-mediated delivery of methotrexate across the blood–brain barrier
description Xiang Wang,1 Ping Liu,1 Weixiao Yang,1 Lu Li,1 Peijing Li,2 Zheng Liu,1 Zhongxiong Zhuo,1 Yunhua Gao1 1Department of Ultrasound, Xinqiao Hospital of the Third Military Medical University, Chongqing, 2Department of Ultrasound, General Hospital of the Jinan Military Area, Jinan, People’s Republic of China Abstract: Methotrexate (MTX) is the single most effective agent for the treatment of primary central nervous system lymphoma. Currently, the delivery of MTX to the brain is achieved by high systemic doses, which cause severe long-term neurotoxicity, or intrathecal administration, which is highly invasive and may lead to infections or hemorrhagic complications. Acoustically active microbubbles have been developed as drug carriers for the noninvasive and brain-targeted delivery of therapeutics. However, their application is limited by their low drug-loading capacity. To overcome this limitation, we prepared microbubbles coupled to MTX-loaded liposomes using ZHIFUXIAN, a novel type of microbubbles with a superior safety profile and long circulation time. MTX-liposome-coupled microbubbles had a high drug-loading capacity of 8.91%±0.86%, and their size (2.64±0.93 µm in diameter) was suitable for intravenous injection. When used with ultrasound, they showed more potent in vitro cytotoxicity against Walker-256 cancer cells than MTX alone or MTX-loaded liposomes. When Sprague-Dawley rats were exposed to sonication, administration of these MTX-liposome-coupled microbubbles via the tail vein led to targeted disruption of the blood–brain barrier without noticeable tissue or capillary damage. High-performance liquid chromatography analysis of the brain MTX concentration showed that MTX delivery to the brain followed the order of MTX-liposome-coupled microbubbles + ultrasound (25.3±2.4 µg/g) > unmodified ZHIFUXIAN + MTX + ultrasound (18.6±2.2 µg/g) > MTX alone (6.97±0.75 µg/g) > MTX-liposome-coupled microbubbles (2.92±0.39 µg/g). Therefore, treatment with MTX-liposome-coupled microbubbles and ultrasound resulted in a significantly higher brain MTX concentration than all other treatments (P<0.01). These results suggest that MTX-liposome-coupled microbubbles may hold great promise as new and effective therapies for primary central nervous system lymphoma and other central nervous system malignancies. Keywords: methotrexate, microbubbles, ultrasound, liposomes, blood–brain barrier
format article
author Wang X
Liu P
Yang W
Li L
Li P
Liu Z
Zhuo Z
Gao Y
author_facet Wang X
Liu P
Yang W
Li L
Li P
Liu Z
Zhuo Z
Gao Y
author_sort Wang X
title Microbubbles coupled to methotrexate-loaded liposomes for ultrasound-mediated delivery of methotrexate across the blood–brain barrier
title_short Microbubbles coupled to methotrexate-loaded liposomes for ultrasound-mediated delivery of methotrexate across the blood–brain barrier
title_full Microbubbles coupled to methotrexate-loaded liposomes for ultrasound-mediated delivery of methotrexate across the blood–brain barrier
title_fullStr Microbubbles coupled to methotrexate-loaded liposomes for ultrasound-mediated delivery of methotrexate across the blood–brain barrier
title_full_unstemmed Microbubbles coupled to methotrexate-loaded liposomes for ultrasound-mediated delivery of methotrexate across the blood–brain barrier
title_sort microbubbles coupled to methotrexate-loaded liposomes for ultrasound-mediated delivery of methotrexate across the blood–brain barrier
publisher Dove Medical Press
publishDate 2014
url https://doaj.org/article/1df4c18cd94d456face78fd477394614
work_keys_str_mv AT wangx microbubblescoupledtomethotrexateloadedliposomesforultrasoundmediateddeliveryofmethotrexateacrossthebloodndashbrainbarrier
AT liup microbubblescoupledtomethotrexateloadedliposomesforultrasoundmediateddeliveryofmethotrexateacrossthebloodndashbrainbarrier
AT yangw microbubblescoupledtomethotrexateloadedliposomesforultrasoundmediateddeliveryofmethotrexateacrossthebloodndashbrainbarrier
AT lil microbubblescoupledtomethotrexateloadedliposomesforultrasoundmediateddeliveryofmethotrexateacrossthebloodndashbrainbarrier
AT lip microbubblescoupledtomethotrexateloadedliposomesforultrasoundmediateddeliveryofmethotrexateacrossthebloodndashbrainbarrier
AT liuz microbubblescoupledtomethotrexateloadedliposomesforultrasoundmediateddeliveryofmethotrexateacrossthebloodndashbrainbarrier
AT zhuoz microbubblescoupledtomethotrexateloadedliposomesforultrasoundmediateddeliveryofmethotrexateacrossthebloodndashbrainbarrier
AT gaoy microbubblescoupledtomethotrexateloadedliposomesforultrasoundmediateddeliveryofmethotrexateacrossthebloodndashbrainbarrier
_version_ 1718403913253650432